MYCN and hepatocellular carcinoma: Our findings revealed that MI202 selectively inhibited MYCN promoter activity and cell proliferation in JHH7 cells, in both monolayer and sphere cultures but not in Hc cells, suggesting that targeting MYCN transcription offers the potential for developing an HCC-specific therapeutic strategy.